StockGuru Alert: StockGuru Announces Coverage of RxElite Holdings (SOUT)
RxElite Holdings, Inc. Be the First to Know! Stock Guru Profile This company has a dynamite plan for revenue that includes being the United States distributor of the most widely used inhalable anesthetic in the world: Sevoflurane for Minrad International. * Market Size: Total addressable market from pipeline products exceed $2 Billion * Sevoflurane is a $400 Million market in the US, with limited competitors; * Market Growth: US Sevoflurane market growth is forecasted to be 11%-15% year over year (in volume); Growth Strategy: Organic Growth Through # A pipeline of more than ten specialty generic drugs with high barriers…